Jubilant DraxImage receives approval for 12-Hour shelf-life extension from the U.S. Food and Drug Administration for DRAXIMAGE® MAA
October 31, 2017 08:45 ET
|
Jubilant DraxImage
Montreal, QC, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Jubilant DraxImage Inc. (“DraxImage”), a wholly-owned subsidiary of Jubilant Pharma, is pleased to announce the U.S. Food and Drug Administration...
dynaCERT Announces Shares for Debt Settlement
September 22, 2017 16:20 ET
|
dynaCERT Inc.
TORONTO, Sept. 22, 2017 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE:DYA) (OTCQB:DYFSF) ("dynaCERT" or the "Company") announces that in accordance with the agreement previously disclosed in the...
Agile Therapeutics Announces Positive Top-line Phase 3 Results
January 03, 2017 16:11 ET
|
Agile Therapeutics, Inc.
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
GlobalWafers and SunEdison Semiconductor Announce Receipt of Approval from SunEdison Semiconductor’s Shareholders for Proposed Acquisition
November 07, 2016 09:20 ET
|
SunEdison Semiconductor Ltd
HSINCHU, Taiwan and ST. PETERS, Mo., Nov. 07, 2016 (GLOBE NEWSWIRE) -- GlobalWafers Co., Ltd. (“GlobalWafers”) and SunEdison Semiconductor Limited (NASDAQ:SEMI) (“SunEdison Semiconductor”) announced...
SunEdison Semiconductor Announces Regulatory Approvals from Taiwan and Austria for Proposed Acquisition
November 04, 2016 07:15 ET
|
SunEdison Semiconductor Ltd
ST. PETERS, Mo., Nov. 04, 2016 (GLOBE NEWSWIRE) -- SunEdison Semiconductor Limited (NASDAQ:SEMI) (“SunEdison Semiconductor”) announced today that it has received notice that the Investment Committee...
Biotricity Files for FDA 510(k)
June 20, 2016 08:30 ET
|
Biotricity
REDWOOD CITY, Calif., June 20, 2016 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative,...
Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
March 30, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 30, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation by the European Medicines Agency for Ampligen to Treat Patients With Ebola Virus Disease (EVD)
May 11, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, May 11, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") announces that its European subsidiary, Hemispherx Biopharma Europe N.V./S.A.,...
Beamz Interactive, Inc.'s Product Earns Seal of Approval by The National Parenting Center
May 02, 2014 08:01 ET
|
Beamz Interactive, Inc.
SCOTTSDALE, AZ--(Marketwired - May 2, 2014) - Beamz Interactive, Inc. (OTCQB: BZIC), a leading developer of state-of-the-art interactive music products, today announced that the company's Beamz by...
Hemispherx Biopharma Announces Plans to File for Regulatory Approval of Ampligen(R) to Treat Chronic Fatigue Syndrome (CFS) in Three Additional Latin America Countries
March 10, 2014 11:00 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, March 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it and its partner in Latin America, GP Pharm, are planning...